profile  volitionrx ltd vnrx volition menu profile business description volition is a multinational company developing simple easy to use bloodbased cancer tests to accurately diagnose a range of cancers the tests are based on the science of nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream  an indication that cancer is present volitions goal is to make the tests as common and simple to use for both patients and doctors as existing diabetic and cholesterol blood tests volitions research and development activities are currently centred in belgium as the company focuses on bringing its diagnostic products to market first in europe then in the us and ultimately worldwide company info address rue phocas lejeuneparc scientifique crealysisnes  be telephone fax emailinfovolitionrxcom industry classifications sectorhealthcare industrydiagnostics arrowdown arrowleft arrowright arrow chevrondown circlelinkred circlelink close play plus investor relations  volitionrx ltd vnrx volition menu investor relations latest news volitionrx limited to host a conference call regarding a  subject colorectal cancer screening trial with the early detection research network of the us national cancer institute jul   read press release upcoming event  annual meeting of stockholders sep   latest financial results q  quarterly results mar   pdf html earnings release audiowebcast pdf conference call transcript pdf html q filing zip xls html xbrl sign up for email alerts sign up today stock information symbol nyse american vnrx price change shares oustanding  mkt cap volume company overview volition is a multinational company developing simple easy to use bloodbased cancer tests to accurately diagnose a range of cancers the tests are based on the science of nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream  an indication that cancer is present volitions goal is to make the tests as common and simple to use for both patients and doctors as existing diabetic and cholesterol blood tests volitions research and development activities are currently centred in belgium as the company focuses on bringing its diagnostic products to market first in europe then in the us and ultimately worldwide management team executive leadershipboard of directors cameron reynolds mba president  chief executive officer cameron is an experienced entrepreneurial executive with expertise in biotechnology companies he has extensive experience in the management structuring and strategic planning of startup companies and has held positions including chief view full bio jake micallef phd mba chief scientific officer jake is an experienced scientist with expertise in research and development and in the management of early stage biotechnical companies including the manufacturing of biotechnology products and the establishment of manufacturing view full bio gaetan michel phd chief executive officer of belgian volition sprl gaetan has over  years of experience in production management following the completion of his phd in  gaetan joined aat advanced array technology a university of namur spinoff company as project manager in proteomics aat later view full bio jason terrell md chief medical officer  chief executive officer of volition america inc jason has expertise in clinical medicine and in laboratory diagnostics he was educated at hardinsimmon university biochemistry where he graduated summa cum laude also receiving the holland medal of honor he received his doctor of view full bio louise day chief marketing and communications officer louise brings more than  years of marketing sales and leadership experience to her role at volition since  she has served as director and owner of aculd ltd a strategic marketing consultancy specializing in healthcare formerly view full bio david vanston mba fcca chief financial officer david has  years of financial management experience prior to volition and octo telematics david held positions as vice president of excorp medical inc an earlystage company chief financial officer for growhow ltd and vice view full bio rod rootsaert llb corporate secretary rod is an experienced legal and corporate secretary with over ten years’ experience in providing corporate legal and administrative services to startup companies he previously served as corporate secretary for several junior view full bio jasmine kway phd vice president asia jasmine has a proven track record in achieving positive business results by developing strategic business alliances identifying new markets and developing business processes as a thought leade in technology management and view full bio dr martin c faulkes chairman dr martin faulkes has over  years of entrepreneurial and managerial experience as the founder and ceo of several software companies within the united kingdom and the united states from  to  dr faulkes was the founder view full bio cameron reynolds mba president  chief executive officer cameron is an experienced entrepreneurial executive with expertise in biotechnology companies he has extensive experience in the management structuring and strategic planning of startup companies and has held positions including chief view full bio dr alan colman nonexecutive director alan colman obtained a ba degree in biochemistry in oxford  and a phd under john gurdon a pioneer of the field of nuclear transfer at the laboratory of molecular biology in cambridge uk  after a series of academic view full bio guy innes aca nonexecutive director guy archibald innes is a chartered accountant and a member of the institute of chartered accountants in england and wales mr innes has extensive experience in financing and managing technology companies which he gained from serving as view full bio dr edward futcher nonexecutive director dr futcher holds a bsc in physics and a phd in physics from the university of london and has extensive experience in engineering and management in high technology companies  since  dr futcher has held nonexecutive view full bio dr habib skaff nonexecutive director dr habib skaff is a synthetic chemist specializing in the area of nanotechnology as well as founder and ceo of intezyne technologies dr skaff received a phd in polymer science and engineering from the university of massachusetts view full bio ir contact information investor relations volitionrx scott powell t   investorrelationsvolitionrxcom edison advisors tirth patel t   tpateledisongroupcom edison advisors rachel carroll t      rcarrolledisongroupcom transfer agent vstock transfer llc  lafayette place woodmere ny  t  f  infovstocktransfercom wwwvstocktransfercom arrowdown arrowleft arrowright arrow chevrondown circlelinkred circlelink close play plus volitionrx ltd vnrx  product pipeline analysis  update trends share size research report uscanada toll free home globaldata medical equipments volitionrx ltd vnrx  product pipeline analysis  update volitionrx ltd vnrx  product pipeline analysis  update published by  globaldata published date  sep  category  medical equipments no of pages   pages description table of content check discount volitionrx ltd volitionrx is a life science company the company provides non invasive blood tests for cancer it provides products such as nuq and hypergenomics the companys nuq is based on proprietary nucleosomics technology for the measurement and identification of nucleosome structures in the blood volitionrx also develops hypergenomics a technology under development that aims to determine specific epigenetic signatures from cancer biopsies its products have strong ip protection with patent applications in europe the us and worldwide the companys office and laboratory are based in namur belgium it also focuses on the sale of manual andor semiautomated  well enzymelinked immunosorbent assay plates volitionrx is headquartered in singapore this report is a source for data analysis and actionable intelligence on the companys portfolio of pipeline products the report provides key information about the company its major products and brands  the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage scope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company volitionrx ltd the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end date reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contents table of contents list of tables list of figures volitionrx ltd company snapshot volitionrx ltd company overview key information volitionrx ltd pipeline products and clinical trials overview volitionrx ltd pipeline analysis overview key facts volitionrx ltd  major products and services volitionrx ltd pipeline products by development stage volitionrx ltd clinical trials by trial status volitionrx ltd pipeline products overview hypergenomics diagnostic test  colon cancer hypergenomics diagnostic test  colon cancer product overview hypergenomics diagnostic test  leukaemia hypergenomics diagnostic test  leukaemia product overview hypergenomics diagnostic test  prostate cancer hypergenomics diagnostic test  prostate cancer product overview nuq  t nuq  t product overview nuq a nuq a product overview nuq diagnostic test  colorectal cancer nuq diagnostic test  colorectal cancer product overview nuq diagnostic test  colorectal cancer clinical trial nuq diagnostic test  lung cancer nuq diagnostic test  lung cancer product overview nuq diagnostic test  pancreatic cancer nuq diagnostic test  pancreatic cancer product overview nuq endo nuq endo product overview nuqa androgen receptor cell culture elisa kit nuqa androgen receptor cell culture elisa kit product overview nuqa ezh cell culture elisa kit nuqa ezh cell culture elisa kit product overview nuqa hmgb cell culture elisa kit nuqa hmgb cell culture elisa kit product overview nuqa progesterone receptor cell culture elisa kit nuqa progesterone receptor cell culture elisa kit product overview nuqb nuqb product overview nuqm nuqm product overview nuqm gamma  hax cell culture elisa kit nuqm gamma  hax cell culture elisa kit product overview nuqm hkac cell culture elisa kit nuqm hkac cell culture elisa kit product overview nuqm hkme cell culture elisa kit nuqm hkme cell culture elisa kit product overview nuqm hpanac cell culture elisa kit nuqm hpanac cell culture elisa kit product overview nuqm ubiquityl ha cell culture elisa kit nuqm ubiquityl ha cell culture elisa kit product overview nuqv nuqv product overview nuqv mha cell culture elisa kit nuqv mha cell culture elisa kit product overview nuqv mha cell culture elisa kit nuqv mha cell culture elisa kit product overview nuqx nuqx product overview nuqx hydroxymethylated dna cell culture kit nuqx hydroxymethylated dna cell culture kit product overview volitionrx ltd  key competitors volitionrx ltd  key employees volitionrx ltd  locations and subsidiaries head office other locations  subsidiaries recent developments volitionrx ltd recent developments jul   volitionrx announces new chief financial officer jun   volitionrx sells first nuq research use only kits to active motif jun   volitionrx appoints dr habib skaff to board of directors apr   volitionrx announces first published data in anticancer research journal apr   president and ceo of volitionrx issues corporate update mar   new volitionrx study data demonstrates nuq assays high detection rate of prostate cancer and the ability to distinguish between prostate and colorectal cancer jan   volitionrx commences first large clinical trial in collaboration with hvidovre hospital denmark jan   volitionrx commences first large clinical trial in collaboration with hvidovre hospital denmark dec   volitionrx finds simple blood test detects  of colorectal cancers and over  of polyps nov   volitionrx to present at the th annual ld micro conference  appendix methodology about globaldata contact us disclaimer  list of table volitionrx ltd key facts  volitionrx ltd pipeline products and clinical trials overview  volitionrx ltd pipeline products by equipment type  volitionrx ltd pipeline products by indication  volitionrx ltd clinical trials by trial status  volitionrx ltd key facts  volitionrx ltd major products and services  volitionrx ltd number of pipeline products by development stage  volitionrx ltd pipeline products summary by development stage  volitionrx ltd clinical trials by trial status  volitionrx ltd clinical trials summary  hypergenomics diagnostic test  colon cancer  product status  hypergenomics diagnostic test  colon cancer  product description  hypergenomics diagnostic test  leukaemia  product status  hypergenomics diagnostic test  leukaemia  product description  hypergenomics diagnostic test  prostate cancer  product status  hypergenomics diagnostic test  prostate cancer  product description  nuq  t  product status  nuq  t  product description  nuq a  product status  nuq a  product description  nuq diagnostic test  colorectal cancer  product status  nuq diagnostic test  colorectal cancer  product description  nuq diagnostic test  colorectal cancer  evaluate the accuracy of nuq assays as an initial screening tool for detecting colorectal cancer a retrospective  nuq diagnostic test  colorectal cancer  extention of sample size for analyzing the effectiveness of nuq diagnostic test in the diagnosis of colorectal cancer a randomized study  nuq diagnostic test  lung cancer  product status  nuq diagnostic test  lung cancer  product description  nuq diagnostic test  pancreatic cancer  product status  nuq diagnostic test  pancreatic cancer  product description  nuq endo  product status  nuq endo  product description  nuqa androgen receptor cell culture elisa kit  product status  nuqa androgen receptor cell culture elisa kit  product description  nuqa ezh cell culture elisa kit  product status  nuqa ezh cell culture elisa kit  product description  nuqa hmgb cell culture elisa kit  product status  nuqa hmgb cell culture elisa kit  product description  nuqa progesterone receptor cell culture elisa kit  product status  nuqa progesterone receptor cell culture elisa kit  product description  nuqb  product status  nuqb  product description  nuqm  product status  nuqm  product description  nuqm gamma  hax cell culture elisa kit  product status  nuqm gamma  hax cell culture elisa kit  product description  nuqm hkac cell culture elisa kit  product status  nuqm hkac cell culture elisa kit  product description  nuqm hkme cell culture elisa kit  product status  nuqm hkme cell culture elisa kit  product description  nuqm hpanac cell culture elisa kit  product status  nuqm hpanac cell culture elisa kit  product description  nuqm ubiquityl ha cell culture elisa kit  product status  nuqm ubiquityl ha cell culture elisa kit  product description  nuqv  product status  nuqv  product description  nuqv mha cell culture elisa kit  product status  nuqv mha cell culture elisa kit  product description  nuqv mha cell culture elisa kit  product status  nuqv mha cell culture elisa kit  product description  nuqx  product status  nuqx  product description  nuqx hydroxymethylated dna cell culture kit  product status  nuqx hydroxymethylated dna cell culture kit  product description  volitionrx ltd key employees  volitionrx ltd other locations  list of chart volitionrx ltd pipeline products by equipment type  volitionrx ltd pipeline products by development stage  volitionrx ltd clinical trials by trial status  make an enquiry before buying this report please fill the enquiry form below full name  your email  job title  company  phone no  pls affix country code message security code   choose license type  select user license single license user  multiple license user  do you wish to check sample of this report order a sample report have query on this report related news amgen’s repatha gets fast fda review for additional heart benefits more than  of diabetic men have erectile dysfunction trex did not sprint it walked unhackable web communication to be launched by china tetraphases antibiotic eravacycline succeeds stage clinical trial research assistance we will be happy to help you find what you need please call us or write to us  uscanada toll free tel   email  salesresearchmozus volitionrx limited corrects an earlier announcement volitionrx limited corrects an earlier announcement news provided by volitionrx ltd jun    et share this article isnes belgium june   prnewswire  volitionrx limited nyse mkt vnrx today has issued corrections to certain statements made in the press release issued by the company on may   regarding the companys nuq™ colorectal cancer screening triage test due to the companys administrative error professor hans jorgen nielsen from hvidovre hospital university of copenhagen did not have adequate opportunity to review and comment upon the release or approve his included statement prior to its publication the company apologizes unreservedly for this oversight and has significantly revised its data review and reporting policy to prevent similar occurrences in the future triage update in the may th press release we announced results showing that  of colonoscopies could be avoided and almost  of colorectal cancers and  of highrisk adenomas detected while those topline numbers are accurate further detailed analysis carried out during the last month has shown the selected immunoassays individually had a high pvalue and therefore are in the process of being replaced this continuing analytical process is part of an ongoing evaluation of results of lab work to discover and select the most effective immunoassays with the aim of achieving the highest possible results the company looks forward to publishing further detailed analysis of this data as well as results from the ongoing triage pathway design study over the coming months about volition volition is a multinational life sciences company developing simple easy to use bloodbased cancer tests to accurately diagnose a range of cancers the tests are based on the science of nucleosomics® which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid  an indication that disease is present as cancer screening programs become more and more widespread our products aim to help to diagnose a range of cancers quickly simply accurately and cost effectively early diagnosis has the potential to not only prolong the life of patients but also to improve their quality of life volitions research and development activities are currently centered in belgium with additional offices in london texas and singapore as the company focuses on bringing its diagnostic products to market first in europe then in the us and ultimately worldwide for more information about volition visit volitions website httpwwwvolitionrxcom  or connect with us viatwitter httpstwittercomvolitionrx linkedin httpswwwlinkedincomcompanyvolitionrx facebook httpswwwfacebookcomvolitionrx youtube httpswwwyoutubecomuservolitionrx the contents found at volitions website address twitter linkedin facebook and youtube are not incorporated by reference into this document and should not be considered part of this document  the addresses for volitions website twitter linkedin facebook and youtube are included in this document as inactive textual references only safe harbor statement statements in this press release may be forwardlooking statements within the meaning of section a of the securities act of  as amended and section e of the securities exchange act of  as amended that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forwardlooking statements words such as expects anticipates intends plans aims targets believes seeks estimates optimizing potential goal suggests could would should may will and similar expressions identify forwardlooking statements these forwardlooking statements relate to the effectiveness of volitions bodilyfluidbased diagnostic tests as well as volitions ability to develop and successfully commercialize such test platforms for early detection of cancer volitions actual results may differ materially from those indicated in these forwardlooking statements due to numerous risks and uncertainties for instance if volition fails to develop and commercialize diagnostic products it may be unable to execute its plan of operations other risks and uncertainties include volitions failure to obtain necessary regulatory clearances or approvals to distribute and market future products in the clinical ivd market a failure by the marketplace to accept the products in volitions development pipeline or any other diagnostic products volition might develop volition will face fierce competition and volitions intended products may become obsolete due to the highly competitive nature of the diagnostics market and its rapid technological change and other risks identified in volitions most recent annual report on form k and quarterly reports on form q as well as other documents that volition files with the securities and exchange commission these statements are based on current expectations estimates and projections about volitions business based in part on assumptions made by management these statements are not guarantees of future performance and involve risks uncertainties and assumptions that are difficult to predict forwardlooking statements are made as of the date of this release and except as required by law volition does not undertake an obligation to update its forwardlooking statements to reflect future events or circumstances nucleosomics® nuq® nuq™ and hypergenomics® and their respective logos are trademarks andor service marks of volitionrx limited and its subsidiaries all other trademarks service marks and trade names referred to in this press release are the property of their respective owners media  investor contacts louise day volition ldayvolitionrxcom    scott powell volition spowellvolitionrxcom     tirth patel edison advisors tpateledisongroupcom     rachel carroll edison advisors rcarrolledisongroupcom     to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesvolitionrxlimitedcorrectsanearlierannouncementhtml source volitionrx ltd jun    et preview volition to present at the europacolon advocacy masterclass and exhibit at the european society for medical oncology gastrointestinal cancer congress may    et preview volitionrx limited announces final results from  patient clinical trial in denmark to evaluate the performance of its nuqtm triage test my news release contains wide tables view fullscreen also from this source jul    et volition america inc announces a colorectal cancer screening jun    et volition to present at the europacolon advocacy masterclass and explore more news releases in similar topics banking  financial services health care  hospitals medical pharmaceuticals pharmaceuticals you just read volitionrx limited corrects an earlier announcement news provided by volitionrx ltd jun    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search vnrxnyse mkt llc stock quote  volitionrx ltd  bloomberg markets error could not add to watchlist x  watchlist volitionrx ltd vnrxus nyse mkt llc usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry health care equipment  services  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  volitionrx limited to host a conference call regarding a  subject colorectal cancer screening trial with the early detect  volition america inc announces a colorectal cancer screening trial containing approximately  subjects in collaboration  volition to present at the europacolon advocacy masterclass and exhibit at the european society for medical oncology gastroint  volitionrx limited corrects an earlier announcement  volitionrx limited to present at multiple investor conferences in june  a new publication reports that  of colorectal cancers were detected at  specificity in a completed prospective trial usin  volitionrx limited announces first quarter  financial results and business update  volitionrx limited announces final results from  patient clinical trial in denmark to evaluate the performance of its nuq  volitionrx limited schedules first quarter  earnings conference call and business update  volition makes progress with its colorectal cancer screening triage test in both asia and europe there are currently no press releases for this ticker please check back later profile volitionrx limited manufactures epigenetic cancer detection blood tests the companys tests are designed to detect the nucleosome patterns that are specific to cancer in the blood and identify some of the major nucleosome varieties that differ between cancer types address  orchard roadorchard plaza singapore singapore phone  website wwwvolitionrxcom executives board members martin c faulkes chairman cameron reynolds presidentceo david vanston cfotreasurer jacob micallef chief scientific officer rodney rootsaert secretary show more revolutionizing cancer diagnosis  volition rx volition menu in the news may    am utc circulating nucleosomes as new bloodbased biomarkers for detection of colorectal cancer april    pm utc serological biomarkers in triage of fitpositive subjects march    am utc cameron reynolds on stock tube march  march    pm utc share radio catches up with volitions ceo cameron reynolds march    am utc cameron reynolds on danish news january    am utc volitionrx chief hails importance of colorectal cancer screening test ce mark january    am utc edison tv interview with cameron reynolds january    am utc share radio  revolutionising cancer diagnosis greenlight given for new blood test january    am utc audioboom  revolutionising cancer diagnosis greenlight given for new blood test september    am utc volitionrx investor presentation at the richmond club toronto arrowdown arrowleft arrowright arrow chevrondown circlelinkred circlelink close play plus vnrx key statistics  volitionrx ltd financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close volitionrx ltd nyse american vnrx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus volitionrx ltd market closed  quotes are delayed by  min jul    pm vnrx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description volitionrx ltd engages in the development of bloodbased cancer tests its tests are based on the science of nucleosomics which identifies and measures nucleosomes in the bloodstream or other bodily fluid its product nuq is a colorectal cancer screening triage test the company was founded on au volitionrx ltd engages in the development of bloodbased cancer tests its tests are based on the science of nucleosomics which identifies and measures nucleosomes in the bloodstream or other bodily fluid its product nuq is a colorectal cancer screening triage test the company was founded on august   and is headquartered in singapore valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  total debt to enterprise value  efficiency liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  longterm debt to equity  longterm debt to total capital  officers and executives name age officer since title mr cameron john reynolds   president chief executive officer  director mr david vanston cecil   chief financial officer dr jacob vincent micallef   chief scientific officer ms louise day   chief marketing  communications officer mr thomas bygott   directorsales  marketing insider actions – purchase – sale  – number of transactions  date name shares transaction value  habib skaff director      guy archibald innes director      guy archibald innes director      martin c faulkes director      alan colman director    derivativenonderivative trans at  per share   alan colman director    derivativenonderivative trans at  per share   cameron john reynolds president and ceo director    derivativenonderivative trans at  per share   jacob vincent micallef chief scientific officer    derivativenonderivative trans at  per share   rodney gerard rootsaert secretary    derivativenonderivative trans at  per share   cameron john reynolds president and ceo director    derivativenonderivative trans at  per share   jacob vincent micallef chief scientific officer    derivativenonderivative trans at  per share   rodney gerard rootsaert secretary    derivativenonderivative trans at  per share   habib skaff director    derivativenonderivative trans at  per share   habib skaff director    derivativenonderivative trans at  per share   david m kratochvil chief financial officer    acquisition at  per share   cameron john reynolds president and ceo director      cameron john reynolds president and ceo director      cameron john reynolds president and ceo director      cameron john reynolds president and ceo director      cameron john reynolds president and ceo director      cameron john reynolds president and ceo director      guy archibald innes director      martin c faulkes director    derivativenonderivative trans at  per share   martin c faulkes director    derivativenonderivative trans at  per share  newslatestcompanyusvnrx marketwatch news on vnrx no news currently available for vnrx newsnonmarketwatchcompanyusvnrx other news on vnrx volitionrx unit to participate in largescale study to validate biomarkers for crc screening test shares ahead   pm july    seeking alpha a profitable and growing microcap investment bank focused on the biotech sector  pm may    seeking alpha volitionrx vnrx ceo cameron reynolds on q  results  earnings call transcript  am may    seeking alpha q volitionrx ltd  am may    edgar online  edg  q k volitionrx vnrx presents at th annual roth conference  pm march    seeking alpha volitionrxs vnrx ceo cameron reynolds on q  results  earnings call transcript  pm march    seeking alpha study shows volitionrxs crc screening test reduces number of colonoscopies  am feb    seeking alpha  medical companies at forefront of oncology testing  pm jan    gurufocuscom volitionrxs crc screening test ce markd shares up  premarket  am jan    seeking alpha biggest movers in manufacturing stocks now – catb xrm airi cemp  pm jan    investorplacecom biggest movers in manufacturing stocks now – anth pi cvi vnrx  pm dec    investorplacecom biggest movers in manufacturing stocks now – bioa ocul hayn usat  pm nov    investorplacecom volitionrxs vnrx ceo cameron reynolds on q  results  earnings call transcript  pm nov    seeking alpha q volitionrx ltd  am nov    edgar online  edg  q k hottest manufacturing stocks now – alks cerc tvia ptx  am oct    investorplacecom biggest movers in manufacturing stocks now – ocul lnn aezs espr  am oct    investorplacecom hottest manufacturing stocks now – ltea lcut syut synl  pm oct    investorplacecom hottest manufacturing stocks now – bspm nymx mnta kmph  am oct    investorplacecom  health care equipment  supplies stocks to buy now  am oct    investorplacecom hottest manufacturing stocks now – ebs spu adap gbt  am sept    investorplacecom loading more headlines at a glance volitionrx ltd  scotts road no  shaw centre singapore ce  phone  industry medical equipmentsupplies sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for vnrx newspressreleasecompanyusvnrx press releases on vnrx volitionrx limited to host a conference call regarding a  subject colorectal cancer screening trial with the early detection research network of the us national cancer institute  pm july    pr newswire  prf volition america inc announces a colorectal cancer screening trial containing approximately  subjects in collaboration with the early detection research network of the us national cancer institute  am july    pr newswire  prf volition to present at the europacolon advocacy masterclass and exhibit at the european society for medical oncology gastrointestinal cancer congress  am june    pr newswire  prf volitionrx limited corrects an earlier announcement  am june    pr newswire  prf volitionrx limited to present at multiple investor conferences in june  am may    pr newswire  prf a new publication reports that  of colorectal cancers were detected at  specificity in a completed prospective trial using volitions nuqtm assays  am may    pr newswire  prf volitionrx limited announces first quarter  financial results and business update  am may    pr newswire  prf volitionrx limited announces final results from  patient clinical trial in denmark to evaluate the performance of its nuqtm triage test  am may    pr newswire  prf volitionrx limited schedules first quarter  earnings conference call and business update  am may    pr newswire  prf volition makes progress with its colorectal cancer screening triage test in both asia and europe  am april    pr newswire  prf volition opens a new research and development facility in belgium with a state of the art purposebuilt laboratory  am april    pr newswire  prf volitionrx appoints david vanston as chief financial officer  am april    pr newswire  prf volition america inc retains strategic expert in securing nondilutive funding opportunities in the united states  pm march    pr newswire  prf volitionrx limited announces the formation of volition america inc  am march    pr newswire  prf volitionrx limited celebrates ce mark announcement by ringing closing bell at the new york stock exchange  pm march    pr newswire  prf volitionrx limited to ring the new york stock exchange closing bell on monday march th at  pm eastern daylight time  am march    pr newswire  prf volitionrx limited announces full fiscal year  financial results and business update  am march    pr newswire  prf volitionrx limited to present at the th annual roth conference  am march    pr newswire  prf volitionrx limited schedules fourth quarter and full year  earnings conference call and business update  pm march    pr newswire  prf a logistics and pathway design study for volitions ce marked nuqtm triage test has been commenced in the capital region of denmark  am march    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  volitionrx ltd vnrx  product pipeline analysis  update about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in life sciences»diagnostics»diagnostics company reports volitionrx ltd vnrx  product pipeline analysis  update lowest prices guaranteed length publisher published date sku from   pages globaldata july  gbdt lowest prices guaranteed price from  length  pages publisher globaldata published date july  sku gbdt table of contents close window table of contents volitionrx ltd vnrx  product pipeline analysis  update printer format globaldata volitionrx ltd company snapshot volitionrx ltd company overview volitionrx ltd pipeline products and clinical trials overview volitionrx ltd – pipeline analysis overview key facts volitionrx ltd  major products and services volitionrx ltd pipeline products by development stage volitionrx ltd clinical trials by trial status volitionrx ltd pipeline products overview colorectal cancer panel test colorectal cancer panel test product overview hypergenomics diagnostic test  colon cancer hypergenomics diagnostic test  colon cancer product overview hypergenomics diagnostic test  leukaemia hypergenomics diagnostic test  leukaemia product overview hypergenomics diagnostic test  prostate cancer hypergenomics diagnostic test  prostate cancer product overview nuq  a androgen receptor cell culture elisa kit nuq  a androgen receptor cell culture elisa kit product overview nuq  a ezh cell culture elisa kit nuq  a ezh cell culture elisa kit product overview nuq  a hmgb cell culture elisa kit nuq  a hmgb cell culture elisa kit product overview nuq  a oestrogen receptor cell culture elisa kit nuq  a oestrogen receptor cell culture elisa kit product overview nuq  a progesterone receptor cell culture elisa kit nuq  a progesterone receptor cell culture elisa kit product overview nuq  prostate cancer nuq  prostate cancer product overview nuq  prostate cancer clinical trial nuq  t nuq  t product overview nuq diagnostic test  lung cancer nuq diagnostic test  lung cancer product overview nuq diagnostic test  lung cancer clinical trial nuq diagnostic test  pancreatic cancer nuq diagnostic test  pancreatic cancer product overview nuq diagnostic test  pancreatic cancer clinical trial nuq endo nuq endo product overview nuq t assay  colorectal cancer nuq t assay  colorectal cancer product overview nuq v assay  colorectal cancer nuq v assay  colorectal cancer product overview nuq xs assay  colorectal cancer nuq xs assay  colorectal cancer product overview nuq xs assay  colorectal cancer clinical trial nuqb nuqb product overview nuqihc nuqihc product overview nuqm gamma  hax cell culture elisa kit nuqm gamma  hax cell culture elisa kit product overview nuqm hkme cell culture elisa kit nuqm hkme cell culture elisa kit product overview nuqm hkac cell culture elisa kit nuqm hkac cell culture elisa kit product overview nuqm hkme cell culture elisa kit nuqm hkme cell culture elisa kit product overview nuqm hpanac cell culture elisa kit nuqm hpanac cell culture elisa kit product overview nuqm ubiquityl ha cell culture elisa kit nuqm ubiquityl ha cell culture elisa kit product overview nuqv nuqv product overview nuqv mha cell culture elisa kit nuqv mha cell culture elisa kit product overview nuqv mha cell culture elisa kit nuqv mha cell culture elisa kit product overview nuqx hydroxymethylated dna cell culture kit nuqx hydroxymethylated dna cell culture kit product overview nuqx methylated dna cell culture kit nuqx methylated dna cell culture kit product overview volitionrx ltd  key competitors volitionrx ltd  key employees volitionrx ltd  key employee biographies volitionrx ltd  locations and subsidiaries head office other locations  subsidiaries recent developments volitionrx ltd recent developments jun   volitionrx appoints dr edward futcher to board of directors jun   volitionrx publishes study confirming stability of circulating cellfree nucleosomes as biomarkers for cancer diagnostic blood tests may   volitionrx to present data demonstrating accuracy of nuq blood test in detecting colorectal cancer at world endoscopy organization weo meeting may   volitionrx announces first quarter  financial results and business update may   volitionrx initiates clinical trial with german cancer research center dkfz to evaluate nuq blood test for pancreatic cancer apr   volitionrx announces study results showing nuq blood test detects prostate cancer early with significantly higher accuracy than psa test apr   volitionrx appoints louise day as chief marketing and communications officer apr   volitionrx to present at aacr annual meeting and announce first results from prostate cancer study apr   volitionrx announces ce mark for nuq v for detection of colorectal cancer apr   volitionrx announces ce mark for nuq t blood assay for detection of colorectal cancer appendix methodology about globaldata contact us disclaimer list of tablesvolitionrx ltd pipeline products and clinical trials overview volitionrx ltd pipeline products by equipment type volitionrx ltd pipeline products by indication volitionrx ltd clinical trials by trial status volitionrx ltd key facts volitionrx ltd major products and services volitionrx ltd number of pipeline products by development stage volitionrx ltd pipeline products summary by development stage volitionrx ltd clinical trials by trial status volitionrx ltd clinical trials summary colorectal cancer panel test  product status colorectal cancer panel test  product description hypergenomics diagnostic test  colon cancer  product status hypergenomics diagnostic test  colon cancer  product description hypergenomics diagnostic test  leukaemia  product status hypergenomics diagnostic test  leukaemia  product description hypergenomics diagnostic test  prostate cancer  product status hypergenomics diagnostic test  prostate cancer  product description nuq  a androgen receptor cell culture elisa kit  product status nuq  a androgen receptor cell culture elisa kit  product description nuq  a ezh cell culture elisa kit  product status nuq  a ezh cell culture elisa kit  product description nuq  a hmgb cell culture elisa kit  product status nuq  a hmgb cell culture elisa kit  product description nuq  a oestrogen receptor cell culture elisa kit  product status nuq  a oestrogen receptor cell culture elisa kit  product description nuq  a progesterone receptor cell culture elisa kit  product status nuq  a progesterone receptor cell culture elisa kit  product description nuq  prostate cancer  product status nuq  prostate cancer  product description nuq  prostate cancer  a retrospective study to establish the efficacy of volitionrxs nuq test to distinguish anaplastic prostate cancer nuq  prostate cancer  feasibility of volitionrxs proprietary nuq assays in detecting prostate cancer nuq  t  product status nuq  t  product description nuq diagnostic test  lung cancer  product status nuq diagnostic test  lung cancer  product description nuq diagnostic test  lung cancer  clinical confirmatory study evaluatng the accuracy of nuq test in diagnosis of subjects with lung cancer nuq diagnostic test  lung cancer  detection of lung cancer with nuq blood test nuq diagnostic test  pancreatic cancer  product status nuq diagnostic test  pancreatic cancer  product description nuq diagnostic test  pancreatic cancer  clinical trial with german cancer research center dkfz to evaluate nuqr blood test for pancreatic cancer nuq endo  product status nuq endo  product description nuq t assay  colorectal cancer  product status nuq t assay  colorectal cancer  product description nuq v assay  colorectal cancer  product status nuq v assay  colorectal cancer  product description nuq xs assay  colorectal cancer  product status nuq xs assay  colorectal cancer  product description nuq xs assay  colorectal cancer  evaluate the accuracy of nuq assays as an initial screening tool for detecting colorectal cancer a retrospective study nuq xs assay  colorectal cancer  extention of sample size for analyzing the effectiveness of nuq diagnostic test in the diagnosis of colorectal cancer a randomized study nuq xs assay  colorectal cancer  study to target nuq biomarker panel for colorectal polyps nuqb  product status nuqb  product description nuqihc  product status nuqihc  product description nuqm gamma  hax cell culture elisa kit  product status nuqm gamma  hax cell culture elisa kit  product description nuqm hkme cell culture elisa kit  product status nuqm hkme cell culture elisa kit  product description nuqm hkac cell culture elisa kit  product status nuqm hkac cell culture elisa kit  product description nuqm hkme cell culture elisa kit  product status nuqm hkme cell culture elisa kit  product description nuqm hpanac cell culture elisa kit  product status nuqm hpanac cell culture elisa kit  product description nuqm ubiquityl ha cell culture elisa kit  product status nuqm ubiquityl ha cell culture elisa kit  product description nuqv  product status nuqv  product description nuqv mha cell culture elisa kit  product status nuqv mha cell culture elisa kit  product description nuqv mha cell culture elisa kit  product status nuqv mha cell culture elisa kit  product description nuqx hydroxymethylated dna cell culture kit  product status nuqx hydroxymethylated dna cell culture kit  product description nuqx methylated dna cell culture kit  product status nuqx methylated dna cell culture kit  product description volitionrx ltd key employees volitionrx ltd key employee biographies volitionrx ltd subsidiaries list of figuresvolitionrx ltd pipeline products by equipment type volitionrx ltd pipeline products by development stage volitionrx ltd clinical trials by trial status description close window description volitionrx ltd vnrx  product pipeline analysis  update printer format globaldata summaryvolitionrx ltd volitionrx is a life science company that develops diagnostic solutions the company develops bloodbased diagnostic tests for detecting and diagnosing cancer and other diseases it provides elisa diagnostic technology with nucleosome detection and analysis techniques volitionrx develops tests on the basis of nucleosomics biomarker platform designed to identify and measure nucleosomes in the bloodstream or other bodily fluid the company has developed epigenetic nuq assays to detect cancer by detecting nucleosomes containing specific nucleotides modified histones specific histone variants nucleosomeprotein adducts and total blood nucleosome levels the company has its presence in belgium volitionrx is headquartered in singaporethis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescopethe report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developmentsthe report analyzes all pipeline products in development for the company volitionrx ltdthe report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial statusthe report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch datethe report provides detailed description of products in development technical specification and functionsthe report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buydevelop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapedesign and develop your product development marketing and sales strategies by understanding the competitor portfolioto formulate effective research  development strategiesdevelop marketentry and market expansion strategiesexploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust returnplan mergers and acquisitions effectively by identifying key players of the most promising pipeline identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantagedevelop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etcidentify understand and capitalize the next highvalue products that your competitor would add in its portfolio search inside this report close window search inside this report online download  purchase site license  purchase global site license  purchase   research assistance us  intl  download our ebook how to succeed using market research learn how to effectively navigate the market research process to help guide your organization on the journey to success download ebook share this report other tasks printer format order by fax currency converter revolutionizing cancer diagnosis  volition rx volition menu brighter tomorrow volition is a multinational company developing simple easy to use bloodbased cancer tests to accurately diagnose a range of cancers watch company video early diagnosis is key as cancer screening programs become more and more widespread our products can help to diagnose a range of cancers quickly simply accurately and cost effectively early diagnosis has the potential to not only prolong the life of patients but also to improve their quality of life find out more “cancer screening tests can also improve survival and decrease mortality by detecting cancer at an early stage when treatment is more effective” american cancer society current cancer diagnosis frequently involves expensive unpleasant and often invasive testing using our nuq™ technology we aim to make cancer diagnosis as accessible as cholesterol or pregnancy testing dr jake micallef phd mbacso a simple test with a small amount of blood “a bloodbased test offers lower cost  more patientfriendly alternative with higher patient uptake for identifying those who must be offered colonoscopy  those where it’s not needed professor of surgical oncology at university of copenhagen hans jorgennielsen for more information on nuq™click here rethinking the approach to cancer nuq™ represents a powerful step change in rethinking the approach to cancer it is a simple solution to the challenging problem of early cancer diagnosis our expert team volition was established in  when our team saw a chance to bring together the longestablished elisa diagnostic technology with the cuttingedge nucleosome detection and analysis techniques we have grown over the years and are now a collective force of distinct individuals but our aim is the same – to save lives by revolutionizing the way cancer is diagnosed cameron reynolds mba president  chief executive officer cameron is an experienced entrepreneurial executive with expertise in biotechnology companies he has extensive experience in the management structuring and strategic planning of startup companies and has held positions including chief executive officer chief financial officer and nonexecutive director of public and private enterprises cameron was educated at the university of western australia receiving both a bachelor of commerce and an mba readmore jake micallef phd mba chief scientific officer jake is an experienced scientist with expertise in research and development and in the management of early stage biotechnical companies including the manufacturing of biotechnology products and the establishment of manufacturing operations jake received his bsc in biology and chemistry and his phd in physical chemistry from king’s college london in addition he received his msc in chemical pathology from st thomas’ hospital medical school and his mba from imperial college management school  readmore gaetan michel phd chief executive officer of belgian volition sprl gaetan has over  years of experience in production management following the completion of his phd in  gaetan joined aat advanced array technology a university of namur spinoff company as project manager in proteomics aat later became eat eppendorf array technology part of the german eppendorf biotech company where gaetan became production manager and was involved in establishing production processes and equipment from  to  he worked for kitozyme a global manufacturer of biopolymers of fungal origin with its core business in weight management digestive and cardiovascular health  readmore jason terrell md chief medical officer  chief executive officer of volition america jason has expertise in clinical medicine and in laboratory diagnostics he was educated at hardinsimmon university biochemistry where he graduated summa cum laude also receiving the holland medal of honor he received his doctor of medicine from the university of texas medical school at houston and affiliate md anderson cancer center jason has a strong grounding in both medicine and more specifically in diagnostics and product commercialization readmore louise day chief marketing and communications officer louise brings more than  years of marketing sales and leadership experience to her role at volition since  she has served as director and owner of aculd ltd a strategic marketing consultancy specializing in healthcare formerly louise worked in various roles at reckitt benckiser including some overseas posts in paris and new york she holds a bachelor of arts in business studies from sheffield hallam university readmore david vanston mba fcca group chief financial officer david has  years of financial management experience prior to volition and octo telematics david held positions as vice president of excorp medical inc an earlystage company chief financial officer for growhow ltd and vice president europe finance for monster worldwide inc david managed and oversaw the accounting finance tax treasury financial planning and analysis of the business david is a certified chartered accountant and holds an mba from warwick business school readmore rod rootsaert llb corporate secretary rod is an experienced legal and corporate secretary with over ten years’ experience in providing corporate legal and administrative services to startup companies he previously served as corporate secretary for several junior mining companies in the united kingdom rod received a bachelor of laws degree from the university of western australia readmore jasmine kway phd vice president asia jasmine has a proven track record in achieving positive business results by developing strategic business alliances identifying new markets and developing business processes as a thought leader in technology management and commercialization she has worked with numerous health and regulatory bodies across asia and has successfully commercialised technologies and expanded companies into the asian markets jasmine has a bachelor of engineering and a doctor of philosophy in oceanography from the national university of singapore readmore innovation pipeline colorectal cancer pancreatic cancer lung cancer press releases  volitionrx limited to host a conference call regarding a  subject colorectal cancer screening trial with the early detection research network of the us national cancer institute  volition america inc announces a colorectal cancer screening trial containing approximately  subjects in collaboration with the early detection research network of the us national cancer institute social responsibility we plan on funding research in schools and universities in modern biology to understand genetics disease and inheritance arrowdown arrowleft arrowright arrow chevrondown circlelinkred circlelink close play plus revolutionizing cancer diagnosis  volition rx volition menu brighter tomorrow volition is a multinational company developing simple easy to use bloodbased cancer tests to accurately diagnose a range of cancers watch company video early diagnosis is key as cancer screening programs become more and more widespread our products can help to diagnose a range of cancers quickly simply accurately and cost effectively early diagnosis has the potential to not only prolong the life of patients but also to improve their quality of life find out more “cancer screening tests can also improve survival and decrease mortality by detecting cancer at an early stage when treatment is more effective” american cancer society current cancer diagnosis frequently involves expensive unpleasant and often invasive testing using our nuq™ technology we aim to make cancer diagnosis as accessible as cholesterol or pregnancy testing dr jake micallef phd mbacso a simple test with a small amount of blood “a bloodbased test offers lower cost  more patientfriendly alternative with higher patient uptake for identifying those who must be offered colonoscopy  those where it’s not needed professor of surgical oncology at university of copenhagen hans jorgennielsen for more information on nuq™click here rethinking the approach to cancer nuq™ represents a powerful step change in rethinking the approach to cancer it is a simple solution to the challenging problem of early cancer diagnosis our expert team volition was established in  when our team saw a chance to bring together the longestablished elisa diagnostic technology with the cuttingedge nucleosome detection and analysis techniques we have grown over the years and are now a collective force of distinct individuals but our aim is the same – to save lives by revolutionizing the way cancer is diagnosed cameron reynolds mba president  chief executive officer cameron is an experienced entrepreneurial executive with expertise in biotechnology companies he has extensive experience in the management structuring and strategic planning of startup companies and has held positions including chief executive officer chief financial officer and nonexecutive director of public and private enterprises cameron was educated at the university of western australia receiving both a bachelor of commerce and an mba readmore jake micallef phd mba chief scientific officer jake is an experienced scientist with expertise in research and development and in the management of early stage biotechnical companies including the manufacturing of biotechnology products and the establishment of manufacturing operations jake received his bsc in biology and chemistry and his phd in physical chemistry from king’s college london in addition he received his msc in chemical pathology from st thomas’ hospital medical school and his mba from imperial college management school  readmore gaetan michel phd chief executive officer of belgian volition sprl gaetan has over  years of experience in production management following the completion of his phd in  gaetan joined aat advanced array technology a university of namur spinoff company as project manager in proteomics aat later became eat eppendorf array technology part of the german eppendorf biotech company where gaetan became production manager and was involved in establishing production processes and equipment from  to  he worked for kitozyme a global manufacturer of biopolymers of fungal origin with its core business in weight management digestive and cardiovascular health  readmore jason terrell md chief medical officer  chief executive officer of volition america jason has expertise in clinical medicine and in laboratory diagnostics he was educated at hardinsimmon university biochemistry where he graduated summa cum laude also receiving the holland medal of honor he received his doctor of medicine from the university of texas medical school at houston and affiliate md anderson cancer center jason has a strong grounding in both medicine and more specifically in diagnostics and product commercialization readmore louise day chief marketing and communications officer louise brings more than  years of marketing sales and leadership experience to her role at volition since  she has served as director and owner of aculd ltd a strategic marketing consultancy specializing in healthcare formerly louise worked in various roles at reckitt benckiser including some overseas posts in paris and new york she holds a bachelor of arts in business studies from sheffield hallam university readmore david vanston mba fcca group chief financial officer david has  years of financial management experience prior to volition and octo telematics david held positions as vice president of excorp medical inc an earlystage company chief financial officer for growhow ltd and vice president europe finance for monster worldwide inc david managed and oversaw the accounting finance tax treasury financial planning and analysis of the business david is a certified chartered accountant and holds an mba from warwick business school readmore rod rootsaert llb corporate secretary rod is an experienced legal and corporate secretary with over ten years’ experience in providing corporate legal and administrative services to startup companies he previously served as corporate secretary for several junior mining companies in the united kingdom rod received a bachelor of laws degree from the university of western australia readmore jasmine kway phd vice president asia jasmine has a proven track record in achieving positive business results by developing strategic business alliances identifying new markets and developing business processes as a thought leader in technology management and commercialization she has worked with numerous health and regulatory bodies across asia and has successfully commercialised technologies and expanded companies into the asian markets jasmine has a bachelor of engineering and a doctor of philosophy in oceanography from the national university of singapore readmore innovation pipeline colorectal cancer pancreatic cancer lung cancer press releases  volitionrx limited to host a conference call regarding a  subject colorectal cancer screening trial with the early detection research network of the us national cancer institute  volition america inc announces a colorectal cancer screening trial containing approximately  subjects in collaboration with the early detection research network of the us national cancer institute social responsibility we plan on funding research in schools and universities in modern biology to understand genetics disease and inheritance arrowdown arrowleft arrowright arrow chevrondown circlelinkred circlelink close play plus volitionrx ltd vnrx  product pipeline analysis  update infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports volitionrx ltd vnrx  product pipeline analysis   volitionrx ltd vnrx  product pipeline analysis  update wgr  september  global  pages globaldata description table of content sample report enquiry before buy related reports summaryvolitionrx ltd volitionrx is a life science company the company provides non invasive blood tests for cancer it provides products such as nuq and hypergenomics the company’s nuq is based on proprietary nucleosomics technology for the measurement and identification of nucleosome structures in the blood volitionrx also develops hypergenomics a technology under development that aims to determine specific epigenetic signatures from cancer biopsies its products have strong ip protection with patent applications in europe the us and worldwide the company’s office and laboratory are based in namur belgium it also focuses on the sale of manual andor semiautomated  well enzymelinked immunosorbent assay plates volitionrx is headquartered in singaporethis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company volitionrx ltd the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contents table of contents list of tables list of figures volitionrx ltd company snapshot volitionrx ltd company overview key information volitionrx ltd pipeline products and clinical trials overview volitionrx ltd – pipeline analysis overview key facts volitionrx ltd  major products and services volitionrx ltd pipeline products by development stage volitionrx ltd clinical trials by trial status volitionrx ltd pipeline products overview hypergenomics diagnostic test  colon cancer hypergenomics diagnostic test  colon cancer product overview hypergenomics diagnostic test  leukaemia hypergenomics diagnostic test  leukaemia product overview hypergenomics diagnostic test  prostate cancer hypergenomics diagnostic test  prostate cancer product overview nuq  t nuq  t product overview nuq – a nuq – a product overview nuq diagnostic test  colorectal cancer nuq diagnostic test  colorectal cancer product overview nuq diagnostic test  colorectal cancer clinical trial nuq diagnostic test  lung cancer nuq diagnostic test  lung cancer product overview nuq diagnostic test  pancreatic cancer nuq diagnostic test  pancreatic cancer product overview nuq endo nuq endo product overview nuqa androgen receptor cell culture elisa kit nuqa androgen receptor cell culture elisa kit product overview nuqa ezh cell culture elisa kit nuqa ezh cell culture elisa kit product overview nuqa hmgb cell culture elisa kit nuqa hmgb cell culture elisa kit product overview nuqa progesterone receptor cell culture elisa kit nuqa progesterone receptor cell culture elisa kit product overview nuqb nuqb product overview nuqm nuqm product overview nuqm gamma  hax cell culture elisa kit nuqm gamma  hax cell culture elisa kit product overview nuqm hkac cell culture elisa kit nuqm hkac cell culture elisa kit product overview nuqm hkme cell culture elisa kit nuqm hkme cell culture elisa kit product overview nuqm hpanac cell culture elisa kit nuqm hpanac cell culture elisa kit product overview nuqm ubiquityl ha cell culture elisa kit nuqm ubiquityl ha cell culture elisa kit product overview nuqv nuqv product overview nuqv mha cell culture elisa kit nuqv mha cell culture elisa kit product overview nuqv mha cell culture elisa kit nuqv mha cell culture elisa kit product overview nuqx nuqx product overview nuqx hydroxymethylated dna cell culture kit nuqx hydroxymethylated dna cell culture kit product overview volitionrx ltd  key competitors volitionrx ltd  key employees volitionrx ltd  locations and subsidiaries head office other locations  subsidiaries recent developments volitionrx ltd recent developments jul   volitionrx announces new chief financial officer jun   volitionrx sells first nuq research use only kits to active motif jun   volitionrx appoints dr habib skaff to board of directors apr   volitionrx announces first published data in anticancer research journal apr   president and ceo of volitionrx issues corporate update mar   new volitionrx study data demonstrates nuq assays high detection rate of prostate cancer and the ability to distinguish between prostate and colorectal cancer jan   volitionrx commences first large clinical trial in collaboration with hvidovre hospital denmark jan   volitionrx commences first large clinical trial in collaboration with hvidovre hospital denmark dec   volitionrx finds simple blood test detects  of colorectal cancers and over  of polyps nov   volitionrx to present at the th annual ld micro conference appendix methodology about globaldata contact us disclaimer list of tables volitionrx ltd key facts volitionrx ltd pipeline products and clinical trials overview volitionrx ltd pipeline products by equipment type volitionrx ltd pipeline products by indication volitionrx ltd clinical trials by trial status volitionrx ltd key facts volitionrx ltd major products and services volitionrx ltd number of pipeline products by development stage volitionrx ltd pipeline products summary by development stage volitionrx ltd clinical trials by trial status volitionrx ltd clinical trials summary hypergenomics diagnostic test  colon cancer  product status hypergenomics diagnostic test  colon cancer  product description hypergenomics diagnostic test  leukaemia  product status hypergenomics diagnostic test  leukaemia  product description hypergenomics diagnostic test  prostate cancer  product status hypergenomics diagnostic test  prostate cancer  product description nuq  t  product status nuq  t  product description nuq – a  product status nuq – a  product description nuq diagnostic test  colorectal cancer  product status nuq diagnostic test  colorectal cancer  product description nuq diagnostic test  colorectal cancer  evaluate the accuracy of nuq assays as an initial screening tool for detecting colorectal cancer a retrospective nuq diagnostic test  colorectal cancer  extention of sample size for analyzing the effectiveness of nuq diagnostic test in the diagnosis of colorectal cancer a randomized study nuq diagnostic test  lung cancer  product status nuq diagnostic test  lung cancer  product description nuq diagnostic test  pancreatic cancer  product status nuq diagnostic test  pancreatic cancer  product description nuq endo  product status nuq endo  product description nuqa androgen receptor cell culture elisa kit  product status nuqa androgen receptor cell culture elisa kit  product description nuqa ezh cell culture elisa kit  product status nuqa ezh cell culture elisa kit  product description nuqa hmgb cell culture elisa kit  product status nuqa hmgb cell culture elisa kit  product description nuqa progesterone receptor cell culture elisa kit  product status nuqa progesterone receptor cell culture elisa kit  product description nuqb  product status nuqb  product description nuqm  product status nuqm  product description nuqm gamma  hax cell culture elisa kit  product status nuqm gamma  hax cell culture elisa kit  product description nuqm hkac cell culture elisa kit  product status nuqm hkac cell culture elisa kit  product description nuqm hkme cell culture elisa kit  product status nuqm hkme cell culture elisa kit  product description nuqm hpanac cell culture elisa kit  product status nuqm hpanac cell culture elisa kit  product description nuqm ubiquityl ha cell culture elisa kit  product status nuqm ubiquityl ha cell culture elisa kit  product description nuqv  product status nuqv  product description nuqv mha cell culture elisa kit  product status nuqv mha cell culture elisa kit  product description nuqv mha cell culture elisa kit  product status nuqv mha cell culture elisa kit  product description nuqx  product status nuqx  product description nuqx hydroxymethylated dna cell culture kit  product status nuqx hydroxymethylated dna cell culture kit  product description volitionrx ltd key employees volitionrx ltd other locations list of figures volitionrx ltd pipeline products by equipment type volitionrx ltd pipeline products by development stage volitionrx ltd clinical trials by trial status  request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send diagnostics market research reports  diagnostics industry analysis  marketresearchcom about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in market research » life sciences diagnostics market research reports  industry analysis life science diagnostics is a process comprised of the use of logics analytics and experience to determine cause and effect relationships primarily used in the medical field diagnostics is concerned with discovering what type of disease and or condition best describes an individual’s symptomatology diagnostic information is typically collected through personalized history and physical examination and involves the use of one or more diagnostic tests a variety of different types of diagnostic tests are currently in use they include clinical diagnostics diagnostics made based on symptomology laboratory diagnostics diagnostics based primarily on lab results radiological diagnostics diagnostics featuring medical imagery differential diagnostics diagnostics based on all possible medical explanations exclusion diagnostics diagnostics made by the process of elimination remote diagnostics diagnostics done remotely by telemedicine in addition to being medically relevant the diagnostic industry and its various technological components are big business for more information on the diagnostic industry in the life sciences field see the industry reports from marketresearchcom listed below show more show less filter your search filter your search diagnostics company reports  in vitro diagnostics  medical imaging  regulation  europe  global  asia  north america  middle east  south america  oceania  africa  central america  research assistance us  intl  join alert me now receive biweekly email alerts on new research sign up find out more on our blog diagnostics industry research  market reports sort by title az title za price lowtohigh price hightolow date date older first refine your search close window refine your search title publisher keyword priceusd to date any date last month last  months last  months last year last  years region all regions africa    algeria    angola    benin    botswana    burkina faso    burundi    cameroon    cape verde    central african republic    chad    comoros    the congo    the congo    cote divoire    djibouti    egypt    equatorial guinea    eritrea    ethiopia    gabon    the gambia    ghana    guinea    guineabissau    kenya    lesotho    liberia    libya    madagascar    malawi    mali    mauritania    mauritius    mayotte    morocco    mozambique    namibia    niger    nigeria    reunion    rwanda    sao tome and principe    senegal    seychelles    sierra leone    somalia    south africa    south sudan    sudan    swaziland    tanzania    togo    tunisia    uganda    western sahara    zambia    zimbabwe asia    afghanistan    armenia    azerbaijan    bangladesh    bhutan    brunei    cambodia    china    cocos keeling islands    east timor    georgia    hong kong    india    indonesia    japan    kazakhstan    kyrgyzstan    laos    macau    malaysia    maldives    mongolia    myanmar    nepal    north korea    pakistan    papua new guinea    philippines    russia    singapore    south korea    sri lanka    taiwan    tajikistan    thailand    turkey    turkmenistan    uzbekistan    vietnam caribbean    anguilla    antigua and barbuda    aruba    the bahamas    barbados    british virgin islands    cayman islands    cuba    curacao    dominica    dominican republic    grenada    guadeloupe    haiti    jamaica    martinique    montserrat    netherlands antilles    puerto rico    saint kitts and nevis    saint lucia    saint vincent and the grenadines    sint maarten saint maarten    trinidad and tobago    turks and caicos islands    virgin islands central america    belize    costa rica    el salvador    guatemala    honduras    nicaragua    panama europe    albania    andorra    austria    belarus    belgium    bosnia and herzegovina    bulgaria    croatia    czech republic    denmark    estonia    faroe islands    finland    france    germany    gibraltar    greece    guernsey    hungary    iceland    ireland    isle of man    italy    jersey    kosovo    latvia    liechtenstein    lithuania    luxembourg    macedonia    malta    moldova    monaco    netherlands    norway    poland    portugal    romania    san marino    scotland    serbia and montenegro    slovakia    slovenia    spain    sweden    switzerland    ukraine    united kingdom global middle east    bahrain    cyprus    gaza strip    iran    iraq    israel    jordan    kuwait    lebanon    oman    palestinian territories    qatar    saudi arabia    syria    united arab emirates    yemen north america    bermuda    canada    greenland    mexico    united states oceania    american samoa    australia    cook islands    fiji    french polynesia    guam    kiribati    marshall islands    micronesia federated states of    nauru    new caledonia    new zealand    niue    norfolk island    northern mariana islands    palau    samoa    solomon islands    tonga    tuvalu    vanuatu south america    argentina    bolivia    brazil    chile    colombia    ecuador    falkland islands    french guiana    guyana    paraguay    peru    suriname    uruguay    venezuela search global cancer diagnostics market overview  test volume and sales forecasts by country laboratory universe jul    usd  etiology of major types of cancer estimates of the number of laboratories performing cancer tests as well as tenyear test volume and sales forecasts by country contains  pages and  tables please note the  read more india immunodiagnostics market  supplier strategies volume and sales forecasts technology and instrumentation review jul    usd  emerging in the clinical chemistry and immunodiagnostic markets during the next five years the report provides specimen test volume and sales forecasts compares features of leading analyzers profiles key competitors and identifies specific product and  read more mexico immunodiagnostics market  supplier strategies volume and sales forecasts technology and instrumentation review jul    usd  emerging in the clinical chemistry and immunodiagnostic markets during the next five years the report provides specimen test volume and sales forecasts compares features of leading analyzers profiles key competitors and identifies specific product and  read more myanmar immunodiagnostics market  supplier strategies volume and sales forecasts technology and instrumentation review jul    usd  emerging in the clinical chemistry and immunodiagnostic markets during the next five years the report provides specimen test volume and sales forecasts compares features of leading analyzers profiles key competitors and identifies specific product and  read more united arab emirates immunodiagnostics market  supplier strategies volume and sales forecasts technology and instrumentation review jul    usd  business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years the report provides specimen test volume and sales forecasts compares features of leading analyzers profiles key competitors and identifies specific  read more afp testing market  us europe japan  emerging opportunities supplier shares and strategies volume and sales segment forecasts emerging technologies and opportunities jul    usd  the researchers approach major technological breakthroughs in tumor diagnosis and therapy discover new specific antigens and unlock the mystery of the genetic basis of the disease during the next five years the worldwide cancer testing  read more cea testing market  us europe japan  emerging opportunities supplier shares and strategies volume and sales segment forecasts emerging technologies and opportunities jul    usd  the researchers approach major technological breakthroughs in tumor diagnosis and therapy discover new specific antigens and unlock the mystery of the genetic basis of the disease during the next five years the worldwide cancer testing  read more occult blood testing market  us europe japan  emerging opportunities supplier shares and strategies volume and sales segment forecasts emerging technologies and opportunities jul    usd  as the researchers approach major technological breakthroughs in tumor diagnosis and therapy discover new specific antigens and unlock the mystery of the genetic basis of the disease during the next five years the worldwide cancer  read more germany hospital infectious disease testing market  supplier shares and strategies volume and sales forecasts emerging technologies instrumentation and opportunities jul    usd  analysis of the german hospital infectious disease testing market including major issues pertaining to the german hospital laboratory practice as well as key economic regulatory demographic social and technological trends with significant market impact during  read more uk hospital infectious disease testing market  supplier shares and strategies volume and sales forecasts emerging technologies instrumentation and opportunities jul    usd  analysis of the uk hospital infectious disease testing market including major issues pertaining to the uk hospital laboratory practice as well as key economic regulatory demographic social and technological trends with significant market impact during  read more france hospital infectious disease testing market  supplier shares and strategies volume and sales forecasts emerging technologies instrumentation and opportunities jul    usd  analysis of the french hospital microbiology testing market including major issues pertaining to the french hospital laboratory practice as well as key economic regulatory demographic social and technological trends with significant market impact during the  read more germany hospital microbiology market  supplier shares and strategies volume and sales forecasts emerging technologies instrumentation and opportunities jul    usd  the german hospital microbiology testing market including major issues pertaining to the german hospital laboratory practice as well as key economic regulatory demographic social and technological trends with significant market impact during the next ten  read more italy hospital microbiology market  supplier shares and strategies volume and sales forecasts emerging technologies instrumentation and opportunities jul    usd  the italian microbiology disease testing market including major issues pertaining to the italian hospital laboratory practice as well as key economic regulatory demographic social and technological trends with significant market impact during the next ten  read more spain hospital microbiology market  supplier shares and strategies volume and sales forecasts emerging technologies instrumentation and opportunities jul    usd  the spanish hospital microbiology testing market including major issues pertaining to the spanish hospital laboratory practice as well as key economic regulatory demographic social and technological trends with significant market impact during the next ten  read more ca tumor markers testing market  us europe japan  emerging opportunities supplier shares and strategies volume and sales segment forecasts emerging technologies and opportunities jul    usd  explosion as the researchers approach major technological breakthroughs in tumor diagnosis and therapy discover new specific antigens and unlock the mystery of the genetic basis of the disease during the next five years the worldwide  read more japan hospital microbiology market  supplier shares and strategies volume and sales forecasts emerging technologies instrumentation and opportunities jul    usd  the japanese hospital microbiology testing market including major issues pertaining to the japanese hospital laboratory practice as well as key economic regulatory demographic social and technological trends with significant market impact during the next ten  read more us hospital microbiology market  supplier shares and strategies volume and sales forecasts emerging technologies instrumentation and opportunities jul    usd  the us hospital microbiology testing market including major issues pertaining to the us hospital laboratory practice as well as key economic regulatory demographic social and technological trends with significant market impact during the next ten  read more latin america immunodiagnostics analyzers and reagents market  a country analysis  supplier strategies volume and sales forecasts technology and instrumentation review jul    usd  are undergoing significant transformation caused by convergence of new and more stringent regulations advances in diagnostic technologies system engineering automation and it and intensifying competition some segments like routine chemistry are already resembling commodity markets  read more middle east immunodiagnostics analyzers and reagents market  an country analysis  supplier strategies volume and sales forecasts technology and instrumentation review jul    usd  are undergoing significant transformation caused by convergence of new and more stringent regulations advances in diagnostic technologies system engineering automation and it and intensifying competition some segments like routine chemistry are already resembling commodity markets  read more asiapacific immunodiagnostics analyzers and reagents market  a country analysis  supplier strategies volume and sales forecasts technology and instrumentation review jul    usd  of over  clinical chemistry tdm endocrine cancer immunoprotein and abused drug assays performed in both centralized hospitals commercial laboratories and pocdecentralized locations the report explores future market trends forecasts specimen test and sales volume  read more europe immunodiagnostics analyzers and reagents market  a country analysis  supplier shares and strategies volume and sales segment forecasts technology and instrumentation review jul    usd  granular strategic analysis of over  clinical chemistry tdm endocrine cancer immunoprotein and abused drug assays performed in both centralized hospitals commercial laboratories and pocdecentralized locations the report explores future market trends forecasts specimen test  read more global blood banking market outlook  facilities country volume and sales forecasts for typing grouping and infectious disease screening tests jul    usd  facilities performing blood banking tests as well as test volume reagent and instrument sales forecasts for blood typing grouping and infectious disease screening tests by country contains  pages and  tables please note the  read more cancer diagnostic testing instrumentation operating characteristics features and selling prices of leading automated and semiautomated analyzers jul    usd   read more cancer diagnostic technologies assessment of emerging technologies and market applications jul    usd  applications for cancer diagnostic testing also included is a review of competingcomplementing technologies such as ct mri nmr pet and photonics spectroscopy contains  pages please note the delivery time for the electronic version of  read more blood bank instrumentation review typing grouping and nat screening analyzers and strategic profiles of leading suppliers jul    usd  the report also presents strategic assessments of current and emerging suppliers of blood banking products including their sales product portfolios marketing tactics technological knowhow new products in rampd collaborative arrangements and business strategies contains   read more  prev           next  start new browse consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media company reports reports by country view all market areas view all publishers ﻿ volitionrx ltd vnrx product pipeline analysis  update   agriculture and animal care agriculture equipment agricultural implements combine harvesters rotavators tillers tractors animal care animal feed animal health pet crop protection agriculture chemical fertilizer net wrap protected cultivation farming field crops fishing fruits and vegetables irrigation plantations seed conventional seed hybrid seed   automotive transportation and warehousing automotive and automotive components auto components automobiles car rental hybrid vehicles lubricant used vehicles general transportation airlines travel aviation railway travel intermediaries logistics and shipping courier packaging transportation value added services warehousing   banking financial services and insurance banking atm banknote online banking retail banking financial services credit rating financial advisory investment banking payments private equity remittance stock broking vending machines wealth management insurance general insurance health insurance life insurance motor insurance reinsurance loans and advances housing loan online loans vehicle loan   consumer products and retail baby care baby apparel and footwear baby equipment baby food baby personal care maternity products consumer electronics audio systems camera computers and peripherals large appliances lighting mobile phone and accessories consumer services ondemand services cosmetics and personal care breath fresheners cosmeceuticals disposable consumer products eye care flavors  fragrance hair care herbal products hygiene nail care oral care personal accessories skin care toiletries home and office furnishings air purifier and freshner bathing furniture gardening home appliances kitchenware mattress stationery water purifier luxury goods artwork products cruises and yachts gems and jewelry luggage and bags watch sporting equipments bicycle golf textile apparel and footwear apparel and footwear apparel and textile athletic apparel innerwear wholesale and retail departmental stores franchisee grocery store cards   defense and security defense aerospace products air force aircraft components army automation and modernization combat vehicles mro services navigational instruments navy security devices access control cyber security fire alarm intrusion alert it security video survelliance weapon ballistic protection military ammunition   education and recruitment education corporate education e learning higher education pre primary primary secondary teacher training test preparation vocational education recruitment   energy and utilities clean technology biofuel carbon fibre hydro solar waste management wind gas lng natural gas shale gas oil drilling and exploration eor equipments and services fuel dispenser midstream naphtha octg oil storage petroleum fuels refining upstream power electricity generation and transmission inverter and ups nuclear power components reservoir development thermal   food beverage and tobacco alcoholic beverages beer cider country liquor imfl wine dairy products butter cheese cream dairy products milk skim milk powder soymilk whey powder whole milk powder yogurt and ice cream food services catering food kiosks quick service restaurant general food confectionary cooking oil dry fruits flour products food ingredients frozen food gluten organic food packaged food processed food ready to eat spice sugar vending machine non alcoholic beverages bottled water carbonated soft drinks energy  sports drink hot beverage iced tea and coffee juice tobacco products cigar cigarette hookah smokeless tobacco   healthcare diagnostics diagnostic lab in vitro diagnostics sleep apnea general healthcare biotechnology healthcare it home healthcare hospitals and clinics old age homes surgery wellness wound care medical devices aesthetic laser biopsy devices bone growth stimulators cardiovascular consumables dental equipment diagnostic imaging ent neurology devices orthopedic pharmaceuticals active pharmaceutical ingredient blood product crams diabetes nutritional and dietary supplements osteoporosis otc drug pharmaceutical pharmacy stores prescribed drug respiratory vaccine   manufacturing and construction construction materials aluminum bricks and blocks cement ceramics electric material explosives glass hardware materials marbles and granite paper refractory materials roofing products sanitaryware steel windows and doors wood industrial engineering industrial automation interior designing infrastructure construction shipbuilding machinery and parts construction machinery elevator and escalator home automation machinery components pipe and valve power tools pump stamping machine tapes other manufacturing activities msme real estate commercial facility management green building hotel real estate consultancy real estate investment trust residential retail   media and entertainment advertising online advertising outdoor advertising films and animation music stores  instruments online music theater video rental gaming and gambling casino online gaming theme park toys video game information services newspaper and magazines intelligence and analytics marketing public publishing relations tourism medical tourism tv radio and broadcasting cable iptv pay tv   metal mining and chemicals chemicals adhesive and sealants coating fine chemicals organic chemicals paint petrochemicals plastics polymer materials rubber specialty chemicals metals  minerals ferrous metals non ferrous metals mining bauxite mining coal mining copper mining gold mining iron ore mining other mining   public sector and administration legal services public services religion funeral wedding   technology and telecom it and ites e commerce embeded systems hosting ict process outsourcing semiconductor software and digital content technology hardware telecommunications and networking cloud services mobile broadband mvas networking and communication equipment smartphone wireless wireline advanced search  call us now     toll free  query  kenresearchcom  login email address password forgot the password  keep me loggedin new here  join us thanks for registering with us please login your your account register  please be patient your registration is in progress it will take few moment name  password  confirm password  phone no  email id    provide corporate academic email id only in case of personal email id provide linkedin profile link in the company address company name    company name and address is required for invoicing process company address    company name and address is required for invoicing process state  country  select afghanistan algeria argentina australia austria bahamas bangladesh barbados belgium belize bermuda bolivia brazil brunei darussalam bulgaria canada czech republic chile china colombia costa rica croatia denmark dominican republic ecuador egypt estonia england finland france germany guatemala greece honduras hong kong hungary iceland ireland india indonesia iran ireland israel italy jamaica japan jordan kenya kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia maldives malta mexico monaco morocco nepal netherlands new zealand norway pakistan panama paraguay peru philippines poland portugal puerto rico qatar romania russia saudi arabia scotland singapore slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand turkey uganda ukraine united arab emirates united kingdom united states venezuela vietnam yugoslavia wales others pin code  validation   if validation code does not match please refresh the page subscribe for the newsletter     forgot password  email id      forgot password  email id      about us services categories news contact us you are here  home  healthcare  medical devices select a format single user license usd  inr  site license usd  inr  corporate user license usd  inr  alternatively request a quote thanks for submitting the form our marketing team will connect back to you for the budget constraint request a quote name  designation  email  phone no  company name  company url  current budget  security code    if validation code does not match please refresh the page report title  volitionrx ltd vnrxproduct pipeline analysis  update quote request for license type license type   license rights price single user license  electronic pdf for single user no print no copy only internal use usd  site license  electronic pdf for site use across authorised users in a single location with print and copy rights only internal use usd  enterprise wide license  electronic pdf for enterprise wide across multiple locations with print and copy rights only internal use usd    request a customized research thanks for letting us know your requirement our research team will connect back to you for the bespoke requirement request a customized research name  designation  email  phone no  company name  company url  current budget  report title  volitionrx ltd vnrxproduct pipeline analysis  update requirement  timeline  in working days   security code    if validation code does not match please refresh the page quote request for license type license type   license rights price single user license  electronic pdf for single user no print no copy only internal use usd  site license  electronic pdf for site use across authorised users in a single location with print and copy rights only internal use usd  enterprise wide license  electronic pdf for enterprise wide across multiple locations with print and copy rights only internal use usd    request for sample report thank you for submitting the form the concerned team will will get back to you within next  hours thank you for downloading the sample report request for sample report report title  volitionrx ltd vnrxproduct pipeline analysis  update name  designation  email  phone no  company name  company url  security code    if validation code does not match please refresh the page requirement    newsletter by category for regular updates on our latest research reports subscribe newsletter interested areas agriculture and animal care automotive transportation and warehousing banking financial services and insurance consumer products and retail defense and security education and recruitment energy and utilities food beverage and tobacco healthcare manufacturing and construction media and entertainment metal mining and chemicals public sector and administration technology and telecom faq clientele recent viewed reports why ken reasearch compare reports to make purchase decision prepaid account to get you valuable discount customized research for business study purchase the section to save on next research testimonials this is with regards to your report on india pvc pipes and fitting market outlook industry outlook to  this is a very well written report and accept my compliments on the same  mohit mittal consultant kpmg advisory services i am pleased to see the very useful and productive information in the reportvery well structured great presentation reflect professionalism in your research studies mustafa masood financial analyst  coldwell banker riyadh while we still are studying and analysing your reports about vietnam  thailand we would like to convey to your research team that they have done a very good job in compiling so much of information together we hope to see more of such well researched reports all the best  keep it up  prashant bhagwatgeneral manager mahindra we would like to appreciate ken research for their great efforts and wonderful support in providing the market intelligence report for itpc the information statistics and research are well understandable and very clear to the point we are happy with ken research for their good client service ontime delivery of the report and as said the report itself thank you ken research for bringing the valuable output for us we would be looking forward to have more research with you in the near future wish you a success in your business jestin mathew indonesian trade promotion center the report was very interesting and useful for me marketing manager western union business solutions volitionrx ltd vnrxproduct pipeline analysis  update products id  gdmepd  pages   july   region asia  globaldata  equity research report   request for sample report  previous  next summary scope list of figure list of table licence rights companies products executive summary summary volitionrx ltd volitionrx is a life science company that develops diagnostic solutions the company develops bloodbased diagnostic tests for detecting and diagnosing cancer and other diseases it provides elisa diagnostic technology with nucleosome detection and analysis techniques volitionrx develops tests on the basis of nucleosomics biomarker platform designed to identify and measure nucleosomes in the bloodstream or other bodily fluid the company has developed epigenetic nuq assays to detect cancer by detecting nucleosomes containing specific nucleotides modified histones specific histone variants nucleosomeprotein adducts and total blood nucleosome levels the company has its presence in belgium volitionrx is headquartered in singapore this report is a source for data analysis and actionable intelligence on the companys portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage scope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company volitionrx ltd the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end date reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolio contact us ken research ankur gupta head marketing  communications ankur  kenresearchcom  wwwkenresearchcom table of contents table of contents  list of tables  list of figures  volitionrx ltd company snapshot  volitionrx ltd company overview  volitionrx ltd pipeline products and clinical trials overview  volitionrx ltdpipeline analysis overview  key facts  volitionrx ltdmajor products and services  volitionrx ltd pipeline products by development stage  volitionrx ltd clinical trials by trial status  volitionrx ltd pipeline products overview  colorectal cancer panel test  colorectal cancer panel test product overview  hypergenomics diagnostic testcolon cancer  hypergenomics diagnostic testcolon cancer product overview  hypergenomics diagnostic testleukaemia  hypergenomics diagnostic testleukaemia product overview  hypergenomics diagnostic testprostate cancer  hypergenomics diagnostic testprostate cancer product overview  nuqa androgen receptor cell culture elisa kit  nuqa androgen receptor cell culture elisa kit product overview  nuqa ezh cell culture elisa kit  nuqa ezh cell culture elisa kit product overview  nuqa hmgb cell culture elisa kit  nuqa hmgb cell culture elisa kit product overview  nuqa oestrogen receptor cell culture elisa kit  nuqa oestrogen receptor cell culture elisa kit product overview  nuqa progesterone receptor cell culture elisa kit  nuqa progesterone receptor cell culture elisa kit product overview  nuqprostate cancer  nuqprostate cancer product overview  nuqprostate cancer clinical trial  nuqt  nuqt product overview  nuq diagnostic testlung cancer  nuq diagnostic testlung cancer product overview  nuq diagnostic testlung cancer clinical trial  nuq diagnostic testpancreatic cancer  nuq diagnostic testpancreatic cancer product overview  nuq diagnostic testpancreatic cancer clinical trial  nuq endo  nuq endo product overview  nuq t assaycolorectal cancer  nuq t assaycolorectal cancer product overview  nuq v assaycolorectal cancer  nuq v assaycolorectal cancer product overview  nuq xs assaycolorectal cancer  nuq xs assaycolorectal cancer product overview  nuq xs assaycolorectal cancer clinical trial  nuqb  nuqb product overview  nuqihc  nuqihc product overview  nuqm gammahax cell culture elisa kit  nuqm gammahax cell culture elisa kit product overview  nuqm hkme cell culture elisa kit  nuqm hkme cell culture elisa kit product overview  nuqm hkac cell culture elisa kit  nuqm hkac cell culture elisa kit product overview  nuqm hkme cell culture elisa kit  nuqm hkme cell culture elisa kit product overview  nuqm hpanac cell culture elisa kit  nuqm hpanac cell culture elisa kit product overview  nuqm ubiquityl ha cell culture elisa kit  nuqm ubiquityl ha cell culture elisa kit product overview  nuqv  nuqv product overview  nuqv mha cell culture elisa kit  nuqv mha cell culture elisa kit product overview  nuqv mha cell culture elisa kit  nuqv mha cell culture elisa kit product overview  nuqx hydroxymethylated dna cell culture kit  nuqx hydroxymethylated dna cell culture kit product overview  nuqx methylated dna cell culture kit  nuqx methylated dna cell culture kit product overview  volitionrx ltdkey competitors  volitionrx ltdkey employees  volitionrx ltdkey employee biographies  volitionrx ltdlocations and subsidiaries  head office  other locations  subsidiaries  recent developments  volitionrx ltd recent developments  jun   volitionrx appoints dr edward futcher to board of directors  jun   volitionrx publishes study confirming stability of circulating cellfree nucleosomes as biomarkers for cancer diagnostic blood tests  may   volitionrx to present data demonstrating accuracy of nuq blood test in detecting colorectal cancer at world endoscopy organization weo meeting  may   volitionrx announces first quarter  financial results and business update  may   volitionrx initiates clinical trial with german cancer research center dkfz to evaluate nuq blood test for pancreatic cancer  apr   volitionrx announces study results showing nuq blood test detects prostate cancer early with significantly higher accuracy than psa test  apr   volitionrx appoints louise day as chief marketing and communications officer  apr   volitionrx to present at aacr annual meeting and announce first results from prostate cancer study  apr   volitionrx announces ce mark for nuq v for detection of colorectal cancer  apr   volitionrx announces ce mark for nuq t blood assay for detection of colorectal cancer  appendix  methodology  about globaldata  contact us  disclaimer  list of figures volitionrx ltd pipeline products by equipment type  volitionrx ltd pipeline products by development stage  volitionrx ltd clinical trials by trial status  list of tables volitionrx ltd pipeline products and clinical trials overview  volitionrx ltd pipeline products by equipment type  volitionrx ltd pipeline products by indication  volitionrx ltd clinical trials by trial status  volitionrx ltd key facts  volitionrx ltd major products and services  volitionrx ltd number of pipeline products by development stage  volitionrx ltd pipeline products summary by development stage  volitionrx ltd clinical trials by trial status  volitionrx ltd clinical trials summary  colorectal cancer panel testproduct status  colorectal cancer panel testproduct description  hypergenomics diagnostic testcolon cancerproduct status  hypergenomics diagnostic testcolon cancerproduct description  hypergenomics diagnostic testleukaemiaproduct status  hypergenomics diagnostic testleukaemiaproduct description  hypergenomics diagnostic testprostate cancerproduct status  hypergenomics diagnostic testprostate cancerproduct description  nuqa androgen receptor cell culture elisa kitproduct status  nuqa androgen receptor cell culture elisa kitproduct description  nuqa ezh cell culture elisa kitproduct status  nuqa ezh cell culture elisa kitproduct description  nuqa hmgb cell culture elisa kitproduct status  nuqa hmgb cell culture elisa kitproduct description  nuqa oestrogen receptor cell culture elisa kitproduct status  nuqa oestrogen receptor cell culture elisa kitproduct description  nuqa progesterone receptor cell culture elisa kitproduct status  nuqa progesterone receptor cell culture elisa kitproduct description  nuqprostate cancerproduct status  nuqprostate cancerproduct description  nuqprostate cancera retrospective study to establish the efficacy of volitionrxs nuq test to distinguish anaplastic prostate cancer  nuqprostate cancerfeasibility of volitionrxs proprietary nuq assays in detecting prostate cancer  nuqtproduct status  nuqtproduct description  nuq diagnostic testlung cancerproduct status  nuq diagnostic testlung cancerproduct description  nuq diagnostic testlung cancerclinical confirmatory study evaluatng the accuracy of nuq test in diagnosis of subjects with lung cancer  nuq diagnostic testlung cancerdetection of lung cancer with nuq blood test  nuq diagnostic testpancreatic cancerproduct status  nuq diagnostic testpancreatic cancerproduct description  nuq diagnostic testpancreatic cancerclinical trial with german cancer research center dkfz to evaluate nuqr blood test for pancreatic cancer  nuq endoproduct status  nuq endoproduct description  nuq t assaycolorectal cancerproduct status  nuq t assaycolorectal cancerproduct description  nuq v assaycolorectal cancerproduct status  nuq v assaycolorectal cancerproduct description  nuq xs assaycolorectal cancerproduct status  nuq xs assaycolorectal cancerproduct description  nuq xs assaycolorectal cancerevaluate the accuracy of nuq assays as an initial screening tool for detecting colorectal cancer a retrospective study  nuq xs assaycolorectal cancerextention of sample size for analyzing the effectiveness of nuq diagnostic test in the diagnosis of colorectal cancer a randomized study  nuq xs assaycolorectal cancerstudy to target nuq biomarker panel for colorectal polyps  nuqbproduct status  nuqbproduct description  nuqihcproduct status  nuqihcproduct description  nuqm gammahax cell culture elisa kitproduct status  nuqm gammahax cell culture elisa kitproduct description  nuqm hkme cell culture elisa kitproduct status  nuqm hkme cell culture elisa kitproduct description  nuqm hkac cell culture elisa kitproduct status  nuqm hkac cell culture elisa kitproduct description  nuqm hkme cell culture elisa kitproduct status  nuqm hkme cell culture elisa kitproduct description  nuqm hpanac cell culture elisa kitproduct status  nuqm hpanac cell culture elisa kitproduct description  nuqm ubiquityl ha cell culture elisa kitproduct status  nuqm ubiquityl ha cell culture elisa kitproduct description  nuqvproduct status  nuqvproduct description  nuqv mha cell culture elisa kitproduct status  nuqv mha cell culture elisa kitproduct description  nuqv mha cell culture elisa kitproduct status  nuqv mha cell culture elisa kitproduct description  nuqx hydroxymethylated dna cell culture kitproduct status  nuqx hydroxymethylated dna cell culture kitproduct description  nuqx methylated dna cell culture kitproduct status  nuqx methylated dna cell culture kitproduct description  volitionrx ltd key employees  volitionrx ltd key employee biographies  volitionrx ltd subsidiaries  single user license report can be used by individual purchaser only site license report can be shared by unlimited users within one corporate location eg a regional office corporate user license report can be shared globally by unlimited users within the purchasing corporation eg all employees of a single company to know more information on purchase by section please send a mail to query  kenresearchcom   pathgen dx pte ltd clearbridge bioloc pte ltd ab sciex pte ltd volitionrx ltd product pipeline product pipeline key pipeline products by equipment type equipment type therapy area products by therapy area development stage products by development stage milestone products by milestone major products brands no of products device class market territory product name therapy name trial name trial indication summary event type clinical trial milestone product status product description description patent patent details competitors key employees subsidiaries locations news events developments medical devices business description company facts trial phase approval estimated technology product patent details phase trial status trial objective trial design trial site business strategies trends pipeline and technology sales strategies related products in vertical global hemodialysis water treatment plants market research report forecast  to  s  p consulting  page   july  read more global hemodialysis water treatment plants sales market report forecast  to  s  p consulting  page   july  read more global hemodialysis water treatment plants market professional survey report forecast  to  s  p consulting  page   july  read more other reports by publisher nucleus replacementmedical devices pipeline assessment  globaldata  page   june  read more leukemia diagnostic testsmedical devices pipeline assessment  globaldata  page   june  read more positron emission tomography pet systemsmedical devices pipeline assessment  globaldata  page   june  read more company home about us services categories news contact us careers rss feeds quick links blog industry reports equity research reports country research reports deal directory publishers upcoming publication latest publications other links discounted reports discount coupons media releases testimonial terms  conditions privacy policy disclaimer faqs site map contact us ken research pvt ltd a tower b spaze i tech business park sohna road sector  nbspnbspnbspnbspnbspgurgaon haryana   india   follow us wish to know more about us download company brochure for further enquiry careers apply for job your resume has been successfully received hr will connect you within  days in case your resume gets shortlisted come on we need you make a start to an incredible career applicant name job function job function market research associate market research analyst seo executive content writer web designer hr specialist total experience year year            months months year              skills email id  notice period current ctc  expected ctc ctcmonthly expected ctcmonthly phone number validation   if validation code does not match please refresh the page   know how we roll our services engage with us query  kenresearchcom thanks for submitting the form please refer to the attached brochure company brochure name email company name select country select afghanistan algeria argentina australia austria bahamas bangladesh barbados belgium belize bermuda bolivia brazil brunei darussalam bulgaria canada czech republic chile china colombia costa rica croatia denmark dominican republic ecuador egypt estonia england finland france germany guatemala greece honduras hong kong hungary iceland ireland india indonesia iran ireland israel italy jamaica japan jordan kenya kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia maldives malta mexico monaco morocco nepal netherlands new zealand norway pakistan panama paraguay peru philippines poland portugal puerto rico qatar romania russia saudi arabia scotland singapore slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand turkey uganda ukraine united arab emirates united kingdom united states venezuela vietnam yugoslavia wales others phone no validation   if validation code does not match please refresh the page thanks for submitting the form the concerned team will respond to your query in the next  hours engage with us name designation email phone no company name company url select country select afghanistan algeria argentina australia austria bahamas bangladesh barbados belgium belize bermuda bolivia brazil brunei darussalam bulgaria canada czech republic chile china colombia costa rica croatia denmark dominican republic ecuador egypt estonia england finland france germany guatemala greece honduras hong kong hungary iceland ireland india indonesia iran ireland israel italy jamaica japan jordan kenya kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia maldives malta mexico monaco morocco nepal netherlands new zealand norway pakistan panama paraguay peru philippines poland portugal puerto rico qatar romania russia saudi arabia scotland singapore slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand turkey uganda ukraine united arab emirates united kingdom united states venezuela vietnam yugoslavia wales others requirements comments validation   if validation code does not match please refresh the page net wrap  store cards  dry fruits  ondemand services  online music  bicycle  personal accessories  herbal products  food kiosks  upstream  bricks and blocks  stamping machine  hookah  fishing  breath fresheners  respiratory  neurology devices  petrochemicals  power tools  reservoir development  petroleum fuels  audio systems  specialty chemicals  polymer materials  process outsourcing  intelligence and analytics  artwork products  processed food  mro services  aerospace products  bone growth stimulators  midstream  baby equipment  rubber  equipments and services  airlines travel  electricity generation and transmission  fuel dispenser  refining  biopsy devices compare my shortlist compare my shortlist